I'm biased
In patients with T2DM and chronic liver disease attributed to MASLD, the risk of major adverse liver outcomes after GLP-1RA treatment over 10 years fails to decrease (15.8% vs
Gong B, Zhang LY, Pang CP, et al
The presence of carbohydrates and proteins in the meal can enhance the absorption of L-Carnitine and optimize its effectiveness in transporting fatty acids
Ozempic (semaglutide) injection 0.5 mg, 1 mg, or 2 mg and Rybelsus (semaglutide) tablets 7 mg or 14 mg are prescription medicines used: along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes Ozempic is used: to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes and known heart disease to reduce the risk of kidney disease worsening, kidney failure (end-stage kidney disease), and death due to cardiovascular disease in adults with type 2 diabetes and chronic kidney disease Rybelsus is used: to reduce the risk of major cardiovascular events such as heart attack, stroke or death in adults with type 2 diabetes who are at high risk for these events It is not known if Ozempic and Rybelsus are safe and effective for use in children
This landscape illustrates both the promise and challenges: multiple valid targets exist, but translational failures have been common
,aspect=ignore)
